Searching...
Searching...
15 results for “focus strategy”
focus
Can I ask just on the bets that we continuously go back to, how much is too much concentration? When you think about, you know, a portfolio, it's like, hey. Traditionally, in venture, you don't wanna be definitely not more than 10% in one single inve
or it'll look like such a jumbled mess that you as the recipient can't really understand it. That's actually a signal that not only have they kind of boiled it down and they understand it, but they're not able to communicate it in a way that the rest
...focus where there have been some that have really made it through that specialization? I think from a sector perspective, you'd have to look at a couple of things. Is the sector when they say they're in infotech or software, it's so vast that the dri
Even though a 2,000,000,000 or $3,000,000,000 ticket at the total fund level will have very little impact on our concentration risk. Bridging the gap between the two is a challenge, and that too is part of this work we are doing on one fund to try to
to go from that picture of the total portfolio to how people are actually investing. What makes for an outsized concentration risk at the total fund level is gonna look very different than outsized concentration risk at the level of a portfolio owned
...bottom up focus. The one area we tend to be tactical on, and this is not rocket science, but we tend to increase our allocation to directional credit and distress strategies when rates are higher and defaults are higher. Then we tend to do the opposi
is cheap, we can do something with that. We'll find a manager and add to them or whatever it takes. How do you balance the notion of static risk with the concept that there may be something like structured credit that you think is an opportunity? So
I think if you if you're seeing all of your core direct response channels start to saturate, then it's something that you have to start doing. And the assumption is that, like, investing in brand is gonna do one of a few things. It's either going to
industry that are fine, some parts that are struggling a little more. So I think from our perspective, that concentration is probably okay. It's like health care. It's such a vast thing. Are you doing biotech in health care? Are you doing instruments
this is the metric that maps to this step. This is the metric that maps to this step. This is the metric that maps to step C. Right? And then saying, okay, where are we performing at on these metrics right now? And then you need to go through the exe
but also has to have this lens of sensible portfolio construction discipline. Yeah. You really need to thread the needle. A lot of long short equity managers actually run at too low of an exposure, both gross and net exposure, and you need such a tre
Let me hammer that home to the listeners because the amount of conversations I've had in the past fifteen, twenty years where someone was like, oh, well, why is this portfolio underperforming? Why is it outperforming? Why do you have this overexposur
...great strategy. You want that in your portfolio, right, if you can get asset access to it. And so how do you change the the mix? Well, there's a couple of key levers you could do. First of all, you can change the target return to be higher, which ess
...our strategy is attempting to do something different than a market index. We're not trying to replicate market indexes. We're trying to do something very different. For better or worse, your active bet will either do well or do poorly, but you need t
Have a podcast?
Get ranked clips, hooks, and ready-to-post copy from your own episodes. Free to try.